Editas Medicine Inc - EDIT - stock price prediction, stock price target, analyst ratings from 15 analysts
Editas Medicine Inc has a share price target of US$ 4, revenue growth forecast of -66.5%, and profit growth estimate of 46.6% for FY25, based on top 15 analyst calls.